Detection of a Novel Coronavirus Causing Pneumonia in Humans
Abstract
An ongoing bunch of pneumonia cases in Wuhan, China, was brought about by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV).Human contaminations with zoonotic coronaviruses (CoVs), including serious intense respiratory disorder (SARS)- CoV and Middle East respiratory disorder (MERS)- CoV, have raised extraordinary general well being concern universally. A totally exceptional bat root CoV causing serious and deadly pneumonia in people is talked about. Clinical information was gathered and bronchoalveolar lavage (BAL) examples from five patients with extreme pneumonia from Jin Yin-tan Hospital of Wuhan, Hubei region, China. Nucleic acids of the BAL were removed and exposed to cutting edge sequencing. Infection disconnection was regulated. Five patients hospitalized from December 18 to December 29, 2019 gave fever, and dyspnea in the midst of difficulties of intense respiratory disorder. Succession results uncovered the nearness of a formerly obscure b-CoV strain out and out five patients, with 99.8% to 99.9% nucleotide characters among the detaches. These segregates indicated 79.0% nucleotide personality with the arrangement of SARS-CoV (GenBank NC_004718) and 51.8% character with the succession of MERS-CoV (GenBank NC_019843). The infection is phylogenetically nearest to a bat SARS-like CoV (SL-ZC45, GenBank MG772933) with 87.6% to 87.7% nucleotide personality, yet is during a different clade. Besides, these infections have one flawless open perusing outline quality 8, as an additional pointer of bat-source CoVs. In any case, the aminoalkanoic corrosive succession of the provisional receptor-restricting space looks like that of SARS-CoV, showing that these infections may utilize a proportional receptor.
Introduction
Pneumonia connected with the novel strain of coronavirus 2019 (COVID-19) is the most perpetual irresistible infectious disease in people, especially in China, USA, Italy and Spain and is the main source of upsetting typical worldwide general wellbeing. Coronaviruses (CoVs) are a huge group of infections encased with single stranded positive-sense RNA , known since the mid-1960s.For the third time in the same number of decades, a zoonotic coronavirus has crossed species to contaminate human populaces. This infection, temporarily called 2019-nCoV, was first distinguished in Wuhan, China. Coronaviruses (CoVs) are wrapped infections with a solitary positive-stranded RNA genome (~26–32 kb long). They have a place with the subfamily Ortho-coronavirinae under the family Coronaviridae, and are characterized into four genera: Alpha-coronavirus (α), Beta-coronavirus (β), Gamma-coronavirus (γ), and Delta-coronavirus (δ).The viral genome regularly encodes four auxiliary proteins, spike (S), envelope (E), film (M), and nucleocapsid (N), just as a few non-basic proteins and various novel embellishment proteins
The viral genome has been sequenced, and these outcomes related to different reports show that it is 75 to 80% indistinguishable from the SARS-CoV and much more firmly identified with a few bat coronaviruses. CoVs contaminate people and an assortment of avian and mammalian species around the world. There are six CoVs known to contaminate people, including two α-CoVs (229E and NL63) and four β-CoVs (OC43, HKU1, serious intense respiratory disorder [SARS]-CoV, and Middle East respiratory disorder [MERS]-CoV). All human CoVs are zoonotic as a distinctive trademark. Specifically, bats are viewed as a key repository of CoVs, and numerous human CoVs are accepted to have started from bats. Since the start of this century, two zoonotic CoVs, SARS CoV and MERS CoV, have been recognized to cause extreme human ailments. The episode of SARS CoV in 2003 was answerable for 8,093 cases and 795 passings around the world. Since its disclosure in Middle Eastern nations in 2012, MERS-CoV has tainted 2,260 individuals with a present case casualty pace of 35.5%. These episodes have raised general wellbeing worries of the potential for the rise of another novel zoonotic CoV.
A formerly obscure bat-beginning CoV causing serious and deadly pneumonia in five patients from Wuhan, China Grouping results uncovered that this infection, harboringa single open perusing outline quality 8 (ORF8), is phylogenetically nearest to bat SARS-like CoV, however is in a different heredity. Moreover, the amino corrosive grouping of the conditional receptor-restricting domain (RBD)of this new CoV takes after that of SARS-CoV, demonstrating that they may utilize the equivalent receptor. These discoveries feature the critical requirement for normal reconnaissance of the interspecies transmission of bat-source CoV to human .
The study has identified and characterized 2019-nCoV. The viral genome has been sequenced, and these results in conjunction with other reports show that it is 75 to 80% identical to the SARS-CoV and even more closely related to several bat coronaviruses.
Technology involved
The investigation was conducted as per the Declaration of Helsinki and was affirmed by the National Health Commission of China and Ethics Commission of the Jin Yin-tan Hospital of Wuhan.
Bronchoalveolar lavage fluid (BAL) samples were collected from five patients hospitalized with pneumonia in Jin Yin-tan Hospital of Wuhan, Wuhan, Hubei province, China from December 18 to 29, 2019. Information was gathered, including clinical data, demographic characteristics, underlying medical conditions, clinical signs and symptoms, chest radiographic findings, clinical laboratory testing results, traveling history, recent animal exposure, and outcomes. The data collected for the cases were deemed by the National Health Commission of the People’s Republic of China as the contents of a public health outbreak investigation.
Genome sequencing
Genome sequencing is figuring out the order of DNA nucleotides, or bases, in a genome—the order of As, Cs, Gs, and Ts that make up an organism's DNA. The human genome is made up of over 3 billion of these genetic letters.
Genome sequencing
Genome sequencing involves revealing the order of bases present in the entire genome of an organism. Genome sequencing is backed by automated DNA sequencing methods and computer software to assemble the enormous sequence data. It can be divided into four stages: (1) preparation of clones comprising the entire genome of an organism; (2) collection of DNA sequences of clones; (3) generation of contig assembly; and (4) database development.
Virus isolation
Unlike bacteria, many of which can be grown on an artificial nutrient medium, viruses require a living host cell for replication. Infected host cells (eukaryotic or prokaryotic) can be cultured and grown, and then the growth medium can be harvested as a source of virus. Virions in the liquid medium can be separated from the host cells by either centrifugation or filtration. Filters can physically remove anything present in the solution that is larger than the virions; the viruses can then be collected in the filtrate.
Virus Isolation with different samples
The Bronchoalveolar lavage (BAL) specimens were inoculated onto Vero cells (ATCC, CCL-81). All cultures were observed daily for a cytopathic effect (CPE). Maintenance medium containing tosyl-phenylalanine chloromethyl-ketone (TPCK) enzyme at a final concentration of 1 μg/mL was replenished at day 4, and cultures were terminated 7 days after inoculation. The viral particles were negative stained with 1% solution of phosphotungstic acid (pH 7.0) and the morphology was characterized by using 120 kV TECNAI (Thermo Fisher Scientific, Hillsboro, OR, USA) electron microscopy and camera of Gatan832. The culture supernatants of cells demonstrating CPE were mixed with paraformaldehyde, dried onto formvar/carbon-coated grids, and stained.
Immunofluorescence assay
Immunofluorescence assay (IFA) is a standard virologic technique to identify the presence of antibodies by their specific ability to react with viral antigens expressed in infected cells. Immunofluorescence is an assay which is used primarily on biological samples and is classically defined as a procedure to detect antigens in cellular contexts using antibodies. The specificity of antibodies to their antigen is the base for immunofluorescence. The biological samples include tissue and cells. Immunofluorescence allows researchers to evaluate whether or not cells in a particular sample express the antigen in question. In cases where an immunopositive signal is found, immunofluorescence also allows researchers to determine which subcellular compartments are expressing the antigen. Immunofluorescence can be used on cultured cell lines, tissue sections, or individual cells.
Immunofluorescence assay
Spot slides were prepared by applying 20 μl of the virus-infected or non-infected cell suspension onto 12-well Teflon-coated slides. The cells were fixed with 4% paraformaldehyde in 1× phosphate-buffered saline (PBS) for 30 min, washed three times with PBS, blocked, and stained with serum from a convalescent patient or serum from a healthy person for 30 min at 37°C at a dilution of 1:200. Goat anti-human immunoglobulin G conjugated with fluorescein isothiocyanate was used as the secondary antibody (Jackson Immuno Research Laboratories, Inc., West Grove, PA, USA). Nuclei and the cytoplasm were counterstained with 4′,6′-diamidino-2-phenylindole (DAPI) and Evans blue. Fluorescent images were obtained and analyzed using laser-scanning confocal microscopy.
Conclusion
The study identified a previously unknown CoV from patients suffering from severe pneumonia. The whole-genome sequences of the viruses were obtained by a next-generation sequencing approach from all five patients, demonstrating overwhelmingly dominant viral reads in the BAL samples. Among the five novel CoV genome sequences, the nt identities reached up to99.8–99.9%. The viruses successfully isolated from the patients could alsobe effectively recognized by serum from a convalescent patient. These findings primarily indicate that the novel CoV is associated with the pneumonia that developed in these patients. However, it remains to be determined whether this novel CoV is capable of causing similar diseases in experimental animals.
Sequence homology analysis of the viral genome showed that the CoV identified in this study is distinct from any of the known human CoVs, including SARS-CoV and MERS-CoV. The most closely related known viruses are two bat SL-CoVs identified in 2005 in Zhoushan, Zhejiang, China, which is geographically distant from Wuhan,however, the nt identities among the viruses are only 85.7–86.8%. Phylogenetic analysis showed that this virus forms a single clade. Collectively, these data indicate that this CoV should be considered a new species. The outbreak of SARS in 2003 largely boosted awareness of threats caused by emerging CoVs. Consequently, great efforts have been made to monitor novel emerging CoVs and to trace their origins so as to establish a risk assessment and alert system for preventing potential epidemics in the human population. Clarification of the coronavirome in animals, particularly in bats as a key reservoir of a wide range of CoVs, should be a priority for any task force.
Afew striking features of these novel CoVs indicated that they are of bat-origin. First, the genome sequences of the novel CoVs showhigh similarity with that of bat SL-CoV ZC45.The study indicated that these viruses are evolutionarily close to bat SL-CoVs ZXC21 and ZC45.All of these novel CoVs are characteristic features of bat-origin CoVs.
One of the most striking and concerning features of this virus is its ability to cause severe respiratory syndrome. The disease progressed rapidly with a major presentation of lower respiratory pathology.. Development of serological assays would be largely beneficial to detect such types of infection at the population level.
The study identified a novel bat-borne CoV associated with a severe and fatal respiratory disease in humans. The emergence of this virus poses a potential threat to public health. Therefore, clarification of the source and transmission mode of these infections is urgently needed to prevent a potential epidemic.
References
- Zaki AM, van BS, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia. N Engl J Med 2012;367:1814-1820. doi: 10.1056/NEJMoa1211721.
- Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, January 24, 2020.
- WHO. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). https://apps.who.int/iris/handle/10665/70863 2003.
- Tan WJ, Zhao X, Ma XJ, et al. A novel coronavirus genome identified in a cluster of pneumonia cases — Wuhan, China 2019−2020. China CDC Weekly 2020; 2: 61-2.
- Rota PA, Oberste MS, Monroe SS, et al.Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
- Woo PC, Lau SK, Li KS, et al. Molecular diversity of coronaviruses in bats. Virology 2006;351:180-7.
- Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolutionof human coronavirus genomes. Trends Microbiol 2017; 25: 35- 48.
